GENinCode (LON:GENI) Shares Up 11.8% – Here’s What Happened

GENinCode Plc (LON:GENI) shares were up 11.8% during trading on Tuesday . The company traded as high as GBX 1 and last traded at GBX 0.95. 6,288,954 shares changed hands during mid-day trading, an increase of 14% from the average session volume of 5,528,808 shares. The stock had previously closed at GBX 0.85.

GENinCode Stock Down 1.4%

The firm has a 50-day moving average of GBX 0.89 and a two-hundred day moving average of GBX 1.04. The company has a quick ratio of 15.88, a current ratio of 0.93 and a debt-to-equity ratio of 117.74. The company has a market capitalization of £6.68 million, a PE ratio of -0.43 and a beta of 0.56.

GENinCode (LON:GENI) last posted its earnings results on Monday, June 8th. The company reported GBX (2.08) EPS for the quarter. GENinCode had a negative net margin of 185.47% and a negative return on equity of 409.40%. The business had revenue of GBX 308 million during the quarter. Equities research analysts predict that GENinCode Plc will post -7.1299999 earnings per share for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.